Skip to main content
. 2013 Oct 22;6:425. doi: 10.1186/1756-0500-6-425

Table 1.

Association between haplogroup status and invasive serous ovarian cancer risk

Euroeapn
Haplogroup-tagging SNPs Allele Case/control proportions OR (95% CI) P
Haplogroup
H
rs2015062
C
0.53 / 0.50
1.10 (0.82-1.51)
0.54
U
rs28358571, rs2853499, rs2854122
T, A, C
0.19 / 0.20
0.94 (0.64-1.39)
0.77
J
rs2015062, rs2854122, rs28359178
T, C, A
0.10 / 0.09
1.16 (0.70-1.93)
0.61
K
rs28358571
C
0.09 / 0.09
0.98 (0.59-1.65)
1.00
V
rs2015062, rs2853495, rs2853506
T, G, A
0.05 / 0.07
0.63 (0.32-1.23)
0.18
W
rs2854122, rs41535848, rs28357684
T, A, G
0.02 / 0.02
1.12 (0.41-3.49)
0.79
X
rs2853517, rs2854122, rs28357684
G, T, G
0.02 / 0.03
0.67 (0.23-1.94)
0.59
I
rs8896, rs41347846, mt14182
G, C, T
0.00 / 0.00
-
1.00
T rs3088053, rs3926883 A, C NA / NA - 1.00

Table is ordered by haplogroup frequency in cases. Haplogroup tagging MT-SNPs and allele are as reported by Saxena et al., 2006. OR; odd ratio, is calculated for a total of 671 samples (317 cases and 354 controls) assigned a unique haplogroup. P is the Fischer’s exact P-value for testing haplogroup frequency and case status. Haplogroup T could not be assigned because rs3926883 was not genotyped. This SNP did not pass quality control. NA is not available.

HHS Vulnerability Disclosure